Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Endosonics/Cordis

This article was originally published in The Gray Sheet

Executive Summary

Endosonics/Cordis: Sign agreement to extend for an additional three years the firms' August 1994 pact giving Cordis exclusive distribution rights in North America and Europe to Endosonics' intravascular ultrasound imaging equipment and coronary catheter products. As part of the deal, Cordis also has agreed to make "an equity investiment of $5 mil. in Endosonics common stock (350,877 shares at $14.25 per share)" and to provide an undisclosed amount of funds "for joint product and market development programs"...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005484

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel